Serina Therapeutics Inc. (SER) Statistics & Valuation Metrics - Stocknear

Serina Therapeutics Inc.

NYSE: SER · Real-Time Price · USD
5.11
-0.17 (-3.22%)
At close: Sep 05, 2025, 3:55 PM
5.00
-2.09%
After-hours: Sep 05, 2025, 07:30 PM EDT

Serina Therapeutics Statistics

Share Statistics

Serina Therapeutics has 10.25M shares outstanding. The number of shares has increased by 12.23% in one year.

10.25M
12.23%
0.35%
3.44%
3.36M
766
0.63%

Short Selling Information

The latest short interest is 37.83K, so 0.37% of the outstanding shares have been sold short.

37.83K
0.37%
0.62%
3.19

Valuation Ratios

The PE ratio is -3.31 and the forward PE ratio is -2.95. Serina Therapeutics's PEG ratio is 0.01.

-3.31
-2.95
658.37
881.6
57.52
-2.15
0.01
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Serina Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 2.4, with a Debt / Equity ratio of 0.42.

2.4
2.4
0.42
-0.03
-0.02
-32.41

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$4.67K
$-928.42K
12
0.01
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -34% in the last 52 weeks. The beta is 0.76, so Serina Therapeutics's price volatility has been higher than the market average.

0.76
-34%
5.49
5.25
47.87
122,480

Income Statement

In the last 12 months, Serina Therapeutics had revenue of 56K and earned -11.14M in profits. Earnings per share was -1.51.

56K
-138K
-17.05M
-11.14M
-10.49M
-10.68M
-1.51
Full Income Statement

Balance Sheet

The company has 3.67M in cash and 268K in debt, giving a net cash position of 3.4M.

3.67M
268K
3.4M
-44.32M
8.94M
4.43M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -17.14M and capital expenditures -22K, giving a free cash flow of -17.16M.

-17.14M
-22K
-17.16M
-2.33
Full Cash Flow Statement

Margins

Gross margin is -246.43%, with operating and profit margins of -30442.86% and -19894.64%.

-246.43%
-30442.86%
-19894.64%
-19894.64%
-18726.79%
-30442.86%
-30641.07%

Dividends & Yields

SER does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for SER is $13, which is 147.1% higher than the current price. The consensus rating is "Buy".

$13
147.1%
Buy
2
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Mar 15, 2024. It was a backward split with a ratio of 7:250.

Mar 15, 2024
backward
7:250

Scores

-8.24
3